| Stage | DHR | % of rev | TMO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $12.1B | 100.00% | TMO ×1.85 |
| Gross profit | $3.8B | 58.54% | $5.1B | 42.28% | DHR +16.3pp |
| Operating income | $1.2B | 19.00% | $2.3B | 18.65% | DHR +0.4pp |
| Pre-tax income | $1.1B | 17.27% | $2.1B | 17.20% | DHR +0.1pp |
| Net income | $1.2B | 18.84% | $1.7B | 14.23% | DHR +4.6pp |
| Stage | DHR | TMO | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $12.1B100.00% | TMO ×1.85 |
| Gross profit | 58.54%$3.8B | 42.28%$5.1B | DHR +16.3pp |
| Operating income | 19.00%$1.2B | 18.65%$2.3B | DHR +0.4pp |
| Pre-tax income | 17.27%$1.1B | 17.20%$2.1B | DHR +0.1pp |
| Net income |
| 18.84%$1.2B |
| 14.23%$1.7B |
| DHR +4.6pp |
None
No disclosed counterparties: DHR.